0
0
Biontech says it can adapt its vaccine within six weeks should a mutation become necessary. The German pharmaceutical company said it had already made preparations with U.S. partner Pfizer for such an eventuality months ago. Initial batches of the adapted vaccine could be delivered within 100 days, according to the company.
Biontech is currently testing the effectiveness of its own vaccine against the new coronavirus variant first detected in South Africa. “We understand the concern of experts and have immediately initiated investigations into variant B.1.1.529,” a Biontech spokesperson said today.
More detailed data from the laboratory tests are expected in two weeks at the latest, he said. “These data will provide us with information on whether B.1.1.529 could be an escape variant that would require an adjustment of our vaccine if this variant spreads internationally.”
— source: orf.at/picture:gds.ro
This post has already been read 784 times!
